期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Adrenomedullin and diabetes 被引量:1
1
作者 Hoi Kin Wong Fai Tang +1 位作者 Tsang Tommy cheung bernard man yung cheung 《World Journal of Diabetes》 SCIE CAS 2014年第3期364-371,共8页
Adrenomedullin(ADM) is a peptide hormone widely expressed in different tissues, especially in the vasculature. Apart from its vasodilatatory and hypotensive effect, it plays multiple roles in the regulation of hormona... Adrenomedullin(ADM) is a peptide hormone widely expressed in different tissues, especially in the vasculature. Apart from its vasodilatatory and hypotensive effect, it plays multiple roles in the regulation of hormonal secretion, glucose metabolism and inflammatory response. ADM regulates insulin balance and may participate in the development of diabetes. The plasma level of ADM is increased in people with diabetes, while in healthy individuals the plasma ADM concentration remains low. Plasma ADM levels are further increased in patients with diabetic complications. In type 1 diabetes, plasma ADM level is correlated with renal failure and retinopathy, while in type 2 diabetes its level is linked with a wider range of complications. The elevation of ADM level in diabetes may be due to hyperinsulinemia, oxidative stress and endothelial injury. At the same time, a rise in plasma ADM level can trigger the onset of diabetes. Strategies to reduce ADM level should be explored so as to reduce diabetic complications. 展开更多
关键词 ADRENOMEDULLIN DIABETES DIABETIC COMPLICATIONS HYPERGLYCEMIA THERAPEUTICS
下载PDF
Nice new hypertension guidelines 被引量:1
2
作者 bernard man yung cheung Tommy Tsang cheung 《World Journal of Hypertension》 2012年第5期45-49,共5页
The National Institute for Clinical Excellence in the United Kingdom published a new set of guidelines on the management of primary hypertension in August 2011, reflecting some important changes in the diagnosis and t... The National Institute for Clinical Excellence in the United Kingdom published a new set of guidelines on the management of primary hypertension in August 2011, reflecting some important changes in the diagnosis and treatment of hypertension. Ambulatory blood pressure measurement is now the new gold standard for diagnosis. Home blood pressure monitoring is a useful alternative for the diagnosis and monitoring of hypertension. Calcium channel blockers(CCB) and blockers of the renin-angiotensin system have surpassed diuretics and β-blockers as first line options. Patients younger than 55 should receive an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker if the former is not tolerated. Older patients should be started on a CCB. A thiazide diuretic can be added to these two groups for better blood pressure control, but. chorthalidone and indapamide are the preferred diuretics as they showed favorable outcomes in large clinical trials. Treatment with these three drug classes should be sufficient in the majority of patients, but if triple therapy is still insufficient, referral to a hypertension specialist is recommended. Additional diuretic therapy, spironolactone, or an α or β blocker can be used as the fourth line treatment. 展开更多
关键词 Hypertension Guidelines Angiotensin-converting ENZYME inhibitor The National Institute for Clinical Excellence
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部